Evaluation of the Vascular Clinical Trial Program of Metrizamide and Iohexol

Andrew E. : Method for assessment of the reporting standard of clinical trials with roentgen contrast media. Acta radiol. Diagnosis 25 (1984), 55.

Andrew E. Dahlstrøm K. Sveen K. Renaa T. : Amipaque (metrizamide) in vascular use and use in body cavities. A survey of the initial clinical trials. Invest. Radiol. 16 (1981), 455.

Dahlstrøm K. Hvinden G. Holager T. Mowinckel P. Renaa T. Laulund S. : Intravascular studies with iohexol (Omnipaque (R)). Results from the first 49 clinical trials. Europ. J. Radiol. (1984) Accepted for publication.

Boijsen E. Aakhus T. (Editors): Iohexol-Omnipaque. Clinical experience with a new non-ionic contrast medium. Acta radiol. (1983) Suppl. No. 366.

Federal Register. Clinical investigations. Proposed establishment of regulations on obligations of sponsors and monitors, FDA, Septemter 27, 1977.

Federal Register. Obligations of clinical investigators of regulated articles, FDA, August 8, 1978.

Fletcher R. H. Fletcher S. W. : Clinical research in general medical journals. New Engl. J. Med. 301 (1979), 180.

Hemminki E. Quality for clinical trials. A concern of three decades. Meth. Inform. Med. 21 (1982), 81.

Nordic Council of Medicine. Proposed guidelines for the clinical trials of medicines. 1980.

Temple R. : Government viewpoint of clinical trials. Drug Information Journal Jan/June (1982), 10.